FDA approves Tecentriq with Cotellic and Zelboraf for BRAF V600 mutation-positive advanced melanoma July 31, 2020
Tecartus wins accelerated approval from FDA for relapsed or refractory mantle cell lymphoma July 27, 2020
Alzumab approved in India for emergency use to treat CRS in patients with COVID-19-related ARDS July 13, 2020
RSS